Literature DB >> 17785511

Penetration of amphotericin B lipid formulations into pleural effusion.

Stefan Weiler1, Rosa Bellmann-Weiler, Michael Joannidis, Romuald Bellmann.   

Abstract

The penetration of the amphotericin B (AMB) lipid formulations (liposomal AMB, AMB colloidal dispersion, and AMB lipid complex formulations) into pleural effusions in seven critically ill patients was assessed. AMB was detected in all pleural effusion samples at concentrations ranging from 0.02 to 0.43 microg/ml. The penetration ratio was 3 to 44%.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17785511      PMCID： PMC2151422          DOI： 10.1128/AAC.01087-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Clinical practice. Pleural effusion.

Authors:  Richard W Light
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

2.  Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence.

Authors:  Romuald Bellmann; Petra Egger; Christian J Wiedermann
Journal:  Clin Infect Dis       Date:  2003-06-01       Impact factor: 9.079

3.  Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis.

Authors:  Jean-Baptiste Stern; Philippe Girard; Raffaele Caliandro
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  Massive pleural effusions in cryptococcal meningitis.

Authors:  C M Wong; K H Lim; C K Liam
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

5.  Antibiotic levels in empyemic pleural fluid.

Authors:  L R Teixeira; S A Sasse; M A Villarino; T Nguyen; M E Mulligan; R W Light
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

6.  Serum and intraperitoneal levels of amphotericin B and flucytosine during intravenous treatment of critically ill patients with Candida peritonitis.

Authors:  Peter H J van der Voort; E Christiaan Boerma; Jan Peter Yska
Journal:  J Antimicrob Chemother       Date:  2007-03-27       Impact factor: 5.790

7.  Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography.

Authors:  P Egger; R Bellmann; C J Wiedermann
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-09-05

8.  Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.

Authors:  Baudouin Byl; Frédérique Jacobs; Pierre Wallemacq; Camelia Rossi; Philippe de Francquen; Matteo Cappello; Teresinha Leal; Jean-Pierre Thys
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

9.  Penetration and clearance of cefoperazone and moxalactam in pleural fluid.

Authors:  H Yamada; T Iwanaga; H Nakanishi; M Yamaguchi; K Iida
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

Review 10.  In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.

Authors:  A Espinel-Ingroff; K Boyle; D J Sheehan
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785
View more
  10 in total

1.  Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema.

Authors:  Brad Moriyama; Marisa Ditullio; Eleanor Wilson; Stacey A Henning; Scott R Penzak; Robert L Danner; Gennethel Pennick; Michael G Rinaldi; Adrian M Zelazny; Juan Gea-Banacloche; A John Barrett; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

Review 2.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

3.  Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients.

Authors:  R Welte; P Eller; I Lorenz; M Joannidis; R Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Melanoma brain metastases: is it time to reassess the bias?

Authors:  Jaclyn C Flanigan; Lucia B Jilaveanu; Mark Faries; Mario Sznol; Stephan Ariyan; James B Yu; Jonathan P S Knisely; Veronica L Chiang; Harriet M Kluger
Journal:  Curr Probl Cancer       Date:  2011 Jul-Aug       Impact factor: 3.187

5.  Pharmacokinetics of liposomal amphotericin B in pleural fluid.

Authors:  Brad Moriyama; Parizad Torabi-Parizi; Alexandra K Pratt; Stacey A Henning; Gennethel Pennick; Yvonne R Shea; Sinchita Roy Chowdhuri; Michael G Rinaldi; A John Barrett; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

6.  Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.

Authors:  Stefan Weiler; Gerda Falkensammer; Angelika Hammerer-Lercher; Markus Anliker; Helene Vogelsinger; Michael Joannidis; Stefan Dunzendorfer; Markus Stein; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

Review 7.  Tissue penetration of antifungal agents.

Authors:  Timothy Felton; Peter F Troke; William W Hope
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

8.  A 19-year-old woman with pleuritic chest pain.

Authors:  Faisal A Khasawneh; Mansoor Mehmood; Ruba A Halloush
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Mar-Apr       Impact factor: 2.471

Review 9.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

10.  A Case Report of Histoplasma-Associated Empyema Treated With Intravenous Injection and Local Thoracic Irrigation of Amphotericin B Plus Medical Thoracoscopy.

Authors:  Ning Cui; Lijun Wang; Jingming Zhao
Journal:  Front Public Health       Date:  2022-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.